Researchers investigate Big picture view: In the study, researchers at the University of Virginia specifically investigated small-molecule GLP-1 receptor agonists, such as the Food and Drug Administration (FDA)-approved orforglipron, which can be taken orally and are cheaper to produce than their injectable counterparts
Meanwhile, the incidence of epilepsy in patients with T2DM is approximately 35.0 per 10,000 person-years, and long-term use of enzyme-inhibiting ASMs is associated with an increased risk of new-onset T2DM
In patients with hepatic encephalopathy, the impaired reaction of cerebral oxyhemoglobin concentration might occur due to astrocyte swelling and dysfunction 42,43,44 because some reports showed that astrocyte controls the regional cerebral blood flow and provides energy sources such as ketone body and carnitine to the neuron 39,41
Valproate therapy does not deplete carnitine levels in otherwise healthy children
Addressing these proactively improves both treatment outcomes and post-treatment maintenance
